ALFREDO GONZALEZ: Open Payments
NPI 1396730123 · NEW BEDFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 34 payments from 11 companies in 2025. Trend: 2023 $132 · 2024 $528 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 9 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $173 |
| ABBVIE INC. | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 3 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Alkermes, Inc. | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Ardelyx, Inc. | 1 | $23 |
| Braeburn Inc. | 1 | $22 |
Products named: SUBLOCADE, CAPLYTA, VRAYLAR, COBENFY, REXULTI, VIVITROL, INVEGA SUSTENNA, INGREZZA.
Industry payments across MA — which companies pay providers there.
